» Articles » PMID: 25870122

Activation of the Macrophage α7 Nicotinic Acetylcholine Receptor and Control of Inflammation

Overview
Date 2015 Apr 15
PMID 25870122
Citations 93
Authors
Affiliations
Soon will be listed here.
Abstract

Inflammatory responses to stimuli are essential body defenses against foreign threats. However, uncontrolled inflammation may result in serious health problems, which can be life-threatening. The α7 nicotinic acetylcholine receptor, a ligand-gated ion channel expressed in the nervous and immune systems, has an essential role in the control of inflammation. Activation of the macrophage α7 receptor by acetylcholine, nicotine, or other agonists, selectively inhibits production of pro-inflammatory cytokines while leaving anti-inflammatory cytokines undisturbed. The neural control of this regulation pathway was discovered recently and it was named the cholinergic anti-inflammatory pathway (CAP). When afferent vagus nerve terminals are activated by cytokines or other pro-inflammatory stimuli, the message travels through the afferent vagus nerve, resulting in action potentials traveling down efferent vagus nerve fibers in a process that eventually leads to macrophage α7 activation by acetylcholine and inhibition of pro-inflammatory cytokines production. The mechanism by which activation of α7 in macrophages regulates pro-inflammatory responses is subject of intense research, and important insights have thus been made. The results suggest that activation of the macrophage α7 controls inflammation by inhibiting NF-κB nuclear translocation, and activating the JAK2/STAT3 pathway among other suggested pathways. While the α7 is well characterized as a ligand-gated ion channel in neurons, whole-cell patch clamp experiments suggest that α7's ion channel activity, defined as the translocation of ions across the membrane in response to ligands, is absent in leukocytes, and therefore, ion channel activity is generally assumed not to be required for the operation of the CAP. In this perspective, we briefly review macrophage α7 activation as it relates to the control of inflammation, and broaden the current view by providing single-channel currents as evidence that the α7 expressed in macrophages retains its ion translocation activity despite the absence of whole-cell currents. Whether this ion-translocating activity is relevant for the proper operation of the CAP or other important physiological processes remains obscure.

Citing Articles

HIV, smoking, and the brain: a convergence of neurotoxicities.

Orlinick B, Farhadian S AIDS Res Ther. 2025; 22(1):13.

PMID: 39915881 PMC: 11804093. DOI: 10.1186/s12981-025-00714-y.


Nicotine is an Immunosuppressant: Implications for Women's Health and Disease.

White A, Craig A, Richie D, Corley C, Sadek S, Barton H J Neuroimmunol. 2024; 397:578468.

PMID: 39461120 PMC: 11653054. DOI: 10.1016/j.jneuroim.2024.578468.


Navigating the Neuroimmunomodulation Frontier: Pioneering Approaches and Promising Horizons-A Comprehensive Review.

Krsek A, Ostojic L, Zivalj D, Baticic L Int J Mol Sci. 2024; 25(17).

PMID: 39273641 PMC: 11396210. DOI: 10.3390/ijms25179695.


Research progress in the pathogenesis of sepsis-associated encephalopathy.

Zhou Y, Bai L, Tang W, Yang W, Sun L Heliyon. 2024; 10(12):e33458.

PMID: 39027435 PMC: 11254713. DOI: 10.1016/j.heliyon.2024.e33458.


Serum autoantibodies against α7-nicotinic receptors in subgroups of patients with bipolar disorder or schizophrenia: clinical features and link with peripheral inflammation.

Darrau E, Jacquemet E, Pons S, Schlick L, Zouridakis M, Wu C Transl Psychiatry. 2024; 14(1):146.

PMID: 38485715 PMC: 10940727. DOI: 10.1038/s41398-024-02853-8.


References
1.
Changeux J, Edelstein S . Allosteric receptors after 30 years. Neuron. 1998; 21(5):959-80. DOI: 10.1016/s0896-6273(00)80616-9. View

2.
Arias H . Binding sites for exogenous and endogenous non-competitive inhibitors of the nicotinic acetylcholine receptor. Biochim Biophys Acta. 1998; 1376(2):173-220. DOI: 10.1016/s0304-4157(98)00004-5. View

3.
Wang H, Liao H, Ochani M, Justiniani M, Lin X, Yang L . Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat Med. 2004; 10(11):1216-21. DOI: 10.1038/nm1124. View

4.
Hurst R, Hajos M, Raggenbass M, Wall T, Higdon N, Lawson J . A novel positive allosteric modulator of the alpha7 neuronal nicotinic acetylcholine receptor: in vitro and in vivo characterization. J Neurosci. 2005; 25(17):4396-405. PMC: 6725110. DOI: 10.1523/JNEUROSCI.5269-04.2005. View

5.
de Jonge W, van der Zanden E, The F, Bijlsma M, van Westerloo D, Bennink R . Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway. Nat Immunol. 2005; 6(8):844-51. DOI: 10.1038/ni1229. View